Biotechnology, Health and Business in Canada, the United States and Worldwide
Tag Archives: GPC Biotech
Here’s the latest collection of M&A news we’ve found since the last update. No new mega-deals, although Sanofi is shopping in the €15 billion range and Roche sold $16 billion of debt (which has seen high demand in subsequent trading) in the largest offering ever to raise cash for its Genentech bid. Also, CV Therapeutics‘ (Nasdaq: CVTX) Board rejected Astellas’ $16 per share bid on the same day CV Therapeutics released its year-end results.